CLINICAL_TRIALS
trial_result
· 2025-10-21
Clinical Trial Update: Open-label Safety Trial of PH94B in Social Anxiety Disorder (SAD) [Phase 3]
Summary
Open-label safety trial of PH94B in social anxiety disorder was terminated, with results posted in October 2025.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: VistaGen Therapeutics, Inc. | Conditions: Social Anxiety Disorder | Phase 3 | Status: TERMINATED | Results posted: 2025-10-21